Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'btk inhibitor 1'

Search results for: 'btk inhibitor 1'

Items 11-20 of 43

Page
per page
  1. L-755,507
    B6970 L-755,507
    Summary: β3 adrenergic receptor agonist
      Soluble in DMSO
  2. IRL-2500
    B6872 IRL-2500
    Target: ETA Receptors|ETB Receptors
    Summary: endothelin receptor antagonist
  3. AVE 0991
    B1007 AVE 0991
     1 Citation
    Target: Angiotensin AT1 Receptors
    Summary: Agonist of angiotensin-(1-7) receptor
      ≥29.04 mg/mL
  4. Exendin-4
    A3408 Exendin-4
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1 activator
      ≥145 mg/mL
  5. Azilsartan
    B2210 Azilsartan
    Target: Angiotensin AT1 Receptors
    Summary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
      insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL
  6. SEA0400
    A3811 SEA0400
     4 Citation
    Target: Na /Ca2 Exchangers (NCXs)
    Summary: Specific inhibitor of Na+/Ca2+ exchange
      insoluble in H2O; ≥18.57 mg/mL
  7. Exendin-3 (9-39) amide
    B6943 Exendin-3 (9-39) amide
     1 Citation
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1 receptor antagonist
      ≥168.5 mg/mL
  8. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: Glucagon receptor/IGF-1R antagonist
      ≥24.05 mg/mL
  9. Perindopril
    B1214 Perindopril
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE inhibitor
      Soluble in DMSO
  10. AHU-377(Sacubitril)
    B1070 AHU-377(Sacubitril)
    Target: neprilysin
    Summary: Neprilysin inhibitor
      ≥41.1 mg/mL

Items 11-20 of 43

Page
per page
Shop By
Now Shopping by
  1. Category GPCR/G protein Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. 5-HT Receptor 11item
  2. Adenosine Receptor 2item
  3. Adenosine Kinase 2item
  4. Adrenergic Receptor 3item
  5. Angiotensin Receptor 6item
  6. Cannabinoid Receptor 2item
  7. CCR2 1 item
  8. CXCR 4item
  9. ETB Receptors 1 item
  10. Free Fatty Acid Receptors 1 item
  11. Glucagon Receptor 3item
  12. Leukotriene Receptor 1 item
  13. LPA Receptor 3item
  14. S1P receptor 2item
  15. Ras 1 item
Specificity
  1. Selective 33item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. Adenosine A2A Receptors 1 item
  2. CXCR 4item
  3. Voltage-gated Potassium (KV) Channels 1 item
  4. LPA Receptors 3item
  5. Glucagon-like peptide 1 (GLP-1) receptors 2item
  6. Trk Receptors 1 item
  7. CCR 1 item
  8. Angiotensin AT2 Receptors 1 item
  9. Adenosine Kinases 2item
  10. 5-HT2 Receptors 5item
  11. Insulin and Insulin-like Receptors 1 item
  12. CB1 Receptors 2item
  13. Sphingosine kinases (SphKs) 2item
  14. D2 Receptors 2item
  15. 5-HT1 Receptors 1 item
  16. 5-HT7 Receptors 1 item
  17. Serotonin reuptake 1 item
  18. Angiotensin-Converting Enzymes (ACEs) 1 item
  19. Free Fatty Acid Receptors 1 item
  20. Leukotriene and Related Receptors 1 item
  21. Norepinephrine transporter 1 item
  22. 5-HT Transporters 2item
  23. CB2 Receptors 1 item
  24. Norepinephrine transporters 1 item
  25. Angiotensin AT1 Receptors 3item
  26. Na /Ca2 Exchangers (NCXs) 1 item
  27. Glucagon Receptors 1 item
  28. ETA Receptors 1 item
  29. ETB Receptors 1 item
  30. 5-HT1 Receptor 1 item
  31. neprilysin 1 item
  32. 5-HT4 Receptor 1 item
  33. Adenosine Deaminases 1 item
  34. Serotonin (5-HT) reuptake 1 item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Bladder Diseases 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 2item
  5. Cancer 11item
  6. Colorectal Cancer 3item
  7. Depression 1 item
  8. Glioblastoma 1 item
  9. Heart Failure 1 item
  10. HIV Infections 1 item
  11. Inflammatory Diseases 3item
  12. Kidney Injury Studies 1 item
  13. Leukemia 1 item
  14. Lymphoma 1 item
  15. Melanoma 1 item
  16. Schizophrenia 3item
  17. Squamous Cell Carcinoma 1 item
  18. Type 2 Diabetes 6item